Solid-dosage forms continue to play an essential role in the pharmaceutical marketplace despite the attention the COVID-19 pandemic has focused on parenteral products.
Tim Roberts, Chief Commercial Officer, sat down with Pharma’s Almanac’s Scientific Editor in Chief David Alvaro to discuss the advancements in oncology, the impact of COVID-19 on the industry, and why PCI is well-positioned to be a successful company
The year is 2030, a new variant of the latest virus-X is highly contagious and circulating globally. Alexa has just notified you that your custom-made vaccine strips have been dispatched and will arrive today between 9 and 9:15 a.m.
Biologics are a more complex class of pharmaceuticals to manufacture, package, store and distribute than their chemical counterparts.
When looking for the right CDMO, pharmaceutical companies can help ensure their project’s success by focusing on five primary attributes in their potential partner: quality, flexibility, speed, cost-effectiveness, and experience.
Safe handling of highly potent molecules is complex, and the associated regulatory requirements are growing. As a result, pharmaceutical companies recognize the importance of selecting the right partner for the development.
When it comes to pharmaceutical and biopharmaceutical supply chain expertise who do you trust?
Start your PCI experience today.Your bridge between life-changing therapies and patients.
